Proteomics at the interface of psychology, gut physiology and dysfunction: An underexploited approach that deserves expansion

Expert Review of Proteomics

Volumn 8, Issue 5, 2011, Pages 605-614

  Lopes, Lusa V ^a   Kussmann, Martin ^b,c  

^a Instituto de Medecina Molecular   (Portugal)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

biomarker; CNS; Crohns; ENS; gut; gutbrain axis; IBD; IBS; inflammation; nutrition; proteomics

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CD45 ANTIGEN; CORTICOTROPIN RELEASING FACTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GLUTAMINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 8; LATROPHILIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUROTRANSMITTER RECEPTOR; PEPTIDES AND PROTEINS; SECRETOGRANIN II; TRACE ELEMENT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ANTIGEN EXPRESSION; APOPTOSIS; ARTIFICIAL MILK; BACTERIAL COLONIZATION; BIOINFORMATICS; CANCER RISK; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CHRONIC STRESS; COLON CANCER; COLOSTRUM; CROHN DISEASE; DETOXIFICATION; DIET SUPPLEMENTATION; DIGESTIVE FUNCTION; ENDOCYTOSIS; ENTERIC FEEDING; ENVIRONMENTAL FACTOR; EPIGENETICS; ESCHERICHIA COLI; GABAERGIC SYSTEM; GASTROINTESTINAL INFECTION; HEAVY CHAIN; HOMEOSTASIS; HORMONE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE INNERVATION; LACTOBACILLUS FERMENTUM; MAST CELL; MATERNAL DEPRIVATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENTAL STRESS; MOLECULAR INTERACTION; MYENTERIC PLEXUS; NEUTROPHIL; NONHUMAN; NUTRITIONAL HEALTH; OXIDATIVE STRESS; PATHOGENESIS; PEPTIDOMICS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; PSYCHOLOGY; REVIEW; SIGNAL TRANSDUCTION; STOMACH FUNCTION DISORDER; TISSUE METABOLISM; TREATMENT RESPONSE; ULCERATIVE COLITIS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; BEHAVIOR; CENTRAL NERVOUS SYSTEM; DIGESTION; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL TRACT; HUMANS; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; PROTEOME; PROTEOMICS;

EID: 80054765317     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.11.50     Document Type: Review

References (100)

1. Roberts MA, Mutch DM, German JB. Genomics: food and nutrition. Curr. Opin. Biotechnol. 12, 516-522 (2001). (Pubitemid 32972180)
2. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881-884 (2001). (Pubitemid 32120760)
3. Kussmann M, Affolter M. Proteomic methods in nutrition. Curr. Opin. Clin. Nutr. Metab. Care 9, 575-583 (2006). (Pubitemid 44258032)
4. Kussmann M, Affolter M, Fay LB. Proteomics in nutrition and health. Comb. Chem. High Throughput. Screen. 8, 679-696 (2005). (Pubitemid 41771569)
5. Kussmann M, Rezzi S, Daniel H. Profiling techniques in nutrition and health research. Curr. Opin. Biotechnol. 19, 83-99 (2008).
6. Kussmann M, Affolter M. Proteomics at the center of nutrigenomics: comprehensive molecular understanding of dietary health effects. Nutrition 25(11-12), 1085-1093 (2009).
7. Kussmann M, Krause L, Siffert W. Nutrigenomics: where are we with genetic and epigenetic markers for disposition and susceptibility? Nutr. Rev. 68(Suppl. 1), S38-S47 (2010).
8. Mallick P, Kuster B. Proteomics: a pragmatic perspective. Nat. Biotechnol. 28, 695-709 (2010).
9. Wilkins MR, Gasteiger, E, Sanchez JC, Appel RD, Hochstrasser DF. Protein identification with sequence tags. Curr. Biol. 6, 1543-1544 (1996). (Pubitemid 27050211)
10. Bantscheff M, Eberhard D, Abraham Y, et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 25, 1035-1044 (2007). (Pubitemid 47517638)
11. Lescuyer P, Hochstrasser D, Rabilloud T. How shall we use the proteomics toolbox for biomarker discovery? J. Proteome Res. 6(9), 3371-3376 (2007). (Pubitemid 47522726)
12. Kussmann M, Panchaud A, Affolter M. Proteomics in nutrition: status quo and outlook for biomarkers and bioactives. J. Proteome. Res. 9, 4876-4887 (2010).
13. Hansson J, Panchaud A, Favre L, et al. Time-resolved quantitative proteome analysis of in vivo intestinal development. Mol. Cell Proteomics 10, M110 (2011).
14. Wilson ID, Nicholson JK, Castro-Perez J, et al. High resolution ultra performance liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome Res. 4, 591-598 (2005). (Pubitemid 40548168)
15. Hu Q, Noll RJ, Li H, Makarov A, Hardman M, Graham-Cooks R. The Orbitrap: a new mass spectrometer. J. Mass Spectrom. 40, 430-443 (2005). (Pubitemid 40637866)
16. Johnson JR, Meng FY, Forbes AJ, Cargile BJ, Kelleher NL. Fourier-transform mass spectrometry for automated fragmentation and identification of 5-20 kDa proteins in mixtures. Electrophoresis 23, 3217-3223 (2002). (Pubitemid 35154171)
17. Smith RD. Evolution of ESI-mass spectrometry and Fourier-transform ion cyclotron resonance for proteomics and other biological applications. Int. J. Mass Spectrom. 200, 509-544 (2000). (Pubitemid 32015938)
18. Brock A, Horn DM, Peters EC, et al. An automated matrix-assisted laser desorption/ionization quadrupole Fourier-transform ion cyclotron resonance mass spectrometer for bottom-up proteomics. Anal. Chem. 75, 3419-3428 (2003). (Pubitemid 36871230)
19. de Godoy LM, Olsen JV, de Souza GA, Li G, Mortensen P, Mann M. Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system. Genome Biol. 7, R50 (2006).
20. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994-999 (1999). (Pubitemid 29474856)
21. Ross PL, Huang YN, Marchese JN, et al. Multiplexed protein quantitation in saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 3, 1154-1169 (2004).
22. Panchaud A, Hansson J, Affolter MP, et al. ANIBAL, stable isotope-based quantitative proteomics by aniline and benzoic acid labeling of amino and carboxylic groups. Mol. Cell Proteomics 7, 800-812 (2008). (Pubitemid 351597488)
23. Kuster B, Schirle M, Mallick P, Aebersold R. Scoring proteomes with proteotypic peptide probes. Nat. Rev. Mol. Cell Biol. 6, 577-583 (2005). (Pubitemid 40943048)
24. Mallick P, Schirle M, Chen SS, et al. Computational prediction of proteotypic peptides for quantitative proteomics. Nat. Biotechnol. 25, 125-131 (2007). (Pubitemid 46098780)
25. Panchaud A, Affolter M, Moreillon P, Kussmann M. Experimental and computational approaches to quantitative proteomics: status quo and outlook. J. Proteomics 71, 19-33 (2008). (Pubitemid 351711645)
26. Cans C, Mangano R, Barila D, Neubauer G, Superti-Furga G. Nuclear tyrosine phosphorylation: the beginning of a map. Biochem. Pharmacol. 60, 1203-1215 (2000).
27. Kocher T, Superti-Furga G. Mass spectrometry-based functional proteomics: from molecular machines to protein networks. Nat. Methods 4, 807-815 (2007). (Pubitemid 350055577)
28. Oppermann FS, Gnad F, Olsen JV, et al. Large-scale proteomics analysis of the human kinome. Mol. Cell Proteomics 8, 1751-1764 (2009).
29. Trelle MB, Jensen ON. Functional proteomics in histone research and epigenetics. Expert. Rev. Proteomics 4(4), 491-503 (2007). (Pubitemid 47347597)
30. Hansson J, Bosco N, Favre L, et al. Influence of gut microbiota on mouse B2 B cell ontogeny and function. Mol. Immunol. 48, 1091-1101 (2011).
31. Framson PE, Cho DH, Lee LY, Hershberg RM. Polarized expression and function of the costimulatory molecule CD58 on human intestinal epithelial cells. Gastroenterology 116, 1054-1062 (1999). (Pubitemid 29203015)
32. Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J. Immunol. 174, 4453-4460 (2005).
33. Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124, 993-1000 (2003). (Pubitemid 36389802)
34. Yang SK, Eckmann L, Panja A, Kagnoff MF. Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 113, 1214-1223 (1997). (Pubitemid 27418975)
35. Canny G, Colgan SP. Events at the host-microbial interface of the gastrointestinal tract. I. Adaptation to a microbial world: role of epithelial bactericidal/permeability-increasing protein. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G593-G597 (2005). (Pubitemid 40388168)
36. Wehkamp J, Fellermann K, Herrlinger KR, Bevins CL, Stange EF. Mechanisms of disease: defensins in gastrointestinal diseases. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 406-415 (2005). (Pubitemid 41486093)
37. Meddings JB. Intestinal permeability in Crohns disease. Aliment. Pharmacol. Ther. 3, 47-53 (1997).
38. James SP. Prototypic disorders of gastrointestinal mucosal immune function: Celiac disease and Crohns disease. J. Allergy Clin. Immunol. 115, 25-30 (2005). (Pubitemid 40075417)
39. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102, 448-455 (1995). (Pubitemid 26013210)
40. Farrell RJ, LaMont JT. Microbial factors in inflammatory bowel disease. Gastroenterol. Clin. North Am. 31, 41-62 (2002). (Pubitemid 34733032)
41. Shanahan F. The host-microbe interface within the gut. Best. Pract. Res. Clin. Gastroenterol. 16, 915-931 (2002).
42. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 53(Suppl. 5), V1-V16 (2004). (Pubitemid 39120096)
43. Macfarlane S, Furrie E, Cummings JH, Macfarlane GT. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin. Infect. Dis. 38, 1690-1699 (2004). (Pubitemid 38781660)
44. Ferguson LR, Shelling AN, Browning BL, Huebner C, Petermann I. Genes, diet and inflammatory bowel disease. Mutat. Res. 622, 70-83 (2007). (Pubitemid 47214578)
45. Roy N, Barnett M, Knoch B, Dommels Y, McNabb W. Nutrigenomics applied to an animal model of inflammatory bowel diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutat. Res. 622, 103-116 (2007). (Pubitemid 47224954)
46. Holtmann MH, Krummenauer F, Claas C, et al. Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients. Dig. Dis. Sci. 51, 1516-1524 (2006). (Pubitemid 44379292)
47. Isaacs KL, Sartor RB. Treatment of inflammatory bowel disease with antibiotics. Gastroenterol. Clin. North Am. 33, 335-345 (2004). (Pubitemid 38737275)
48. Sartor RB. Review article: how relevant to human inflammatory bowel disease are current animal models of intestinal inflammation? Aliment. Pharmacol. Ther. 11(Suppl. 3), 89-96 (1997).
49. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohns disease of the colon. Gut 52, 237-242 (2003). (Pubitemid 36115065)
50. Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/ Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54, 242-249 (2005). (Pubitemid 40139241)
51. Groux H, OGarra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742 (1997). (Pubitemid 27458961)
52. Singh B, Read S, Asseman C, et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190-200 (2001). (Pubitemid 33070218)
53. Strober W, Nakamura K, Kitani A. The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease. J. Clin. Invest. 107, 667-670 (2001).
54. Kitani A, Fuss IJ, Nakamura K, Schwartz OM, Usui T, Strober W. Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-b1 plasmid: TGF-b1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor b2 chain downregulation. J. Exp. Med. 192, 41-52 (2000). (Pubitemid 30470805)
55. Kussmann M, Blum S. OMICS-derived targets for inflammatory gut disorders: opportunities for the development of nutrition related biomarkers. Endocr. Metab. Immune Disord. Drug Targets 7, 271-287 (2007).
56. Danielsen M, Thymann T, Jensen BB, Jensen ON, Sangild PT, Bendixen E. Proteome profiles of mucosal immunoglobulin uptake in inflamed porcine gut. Proteomics 6, 6588-6596 (2006). (Pubitemid 46048397)
57. Danielsen M, Hornshoj H, Siggers RH, Jensen BB, van Kessel AG, Bendixen E. Effects of bacterial colonization on the porcine intestinal proteome. J. Proteome Res. 6, 2596-2604 (2007). (Pubitemid 47122354)
58. Jiang P, Sangild PT, Siggers RH, Sit WH, Lee CL, Wan JM. Bacterial colonization affects the intestinal proteome of preterm pigs susceptible to necrotizing enterocolitis. Neonatology 99, 280-288 (2011).
59. Thébault S, Deniel N, Galland A, et al. Human duodenal proteome modulations by glutamine and antioxidants. Proteomics Clin. Appl. 4, 325-336 (2010).
60. Langley JN. Observations on denervated muscle. J. Physiol. 50, 335-344 (1916).
61. Wood JD, Alpers DH, Andrews PL. Fundamentals of neurogastroenterology. Gut 45(Suppl. 2), II6-II16 (1999). (Pubitemid 29434807)
62. Hansen MB. The enteric nervous system I: organisation and classification. Pharmacol. Toxicol. 92, 105-113 (2004).
63. Hansen MB. The enteric nervous system III: a target for pharmacological treatment. Pharmacol. Toxicol. 93, 1-13 (2003). (Pubitemid 36819368)
64. Hansen MB. The enteric nervous system II: gastrointestinal functions. Pharmacol. Toxicol. 92, 249-257 (2003). (Pubitemid 36734982)
65. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 122, 2032-2048 (2002). (Pubitemid 34651445)
66. Barreau F, Ferrier L, Fioramonti J, Bueno L. New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models. Pediatr. Res. 62, 240-245 (2007). (Pubitemid 47301468)
67. Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meaney MJ, Plotsky PM. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog. Brain Res. 122, 81-103 (2000). (Pubitemid 30114471)
68. Coutinho SV, Plotsky PM, Sablad M, et al. Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G307-G316 (2002). (Pubitemid 34651687)
69. Barreau F, Salvador-Cartier C, Houdeau E, Bueno L, Fioramonti J. Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats. Gut 57, 582-590 (2008). (Pubitemid 351579968)
70. Hyland NP, Julio-Pieper M, OMahony SM, et al. A distinct subset of submucosal mast cells undergoes hyperplasia following neonatal maternal separation: a role in visceral hypersensitivity? Gut 58, 31029-31030 (2009).
71. Choi YS, Choe LH, Lee KH. Recent cerebrospinal fluid biomarker studies of Alzheimers disease. Exp. Rev. Proteomics 7(6), 919-929 (2010).
72. Kim SI, Voshol H, van Oostrum J, Hastings TG, Cascio M, Glucksman MJ. Neuroproteomics: expression profiling of the brains proteomes in health and disease. Neurochem. Res. 29, 1317-1331 (2007).
73. Puchades M, Hansson SF, Nilsson CL, Andreasen N, Blennow K, Davidsson P. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimers disease. Brain Res. Mol. Brain Res. 118, 140-146 (2003). (Pubitemid 37238996)
74. Dayon L, Turck N, Garcia-Berrocoso T, et al. Brain extracellular fluid protein changes in acute stroke patients. J. Proteome Res. 10(3), 1043-1051 (2011).
75. Husi H, Grant SGN. Proteomics of the nervous system. Trends Neurosci. 24, 259-266 (2001). (Pubitemid 32304467)
76. Rout MP, Aitchison JD, Suprapto A, Hjertaas K, Zhao Y, Chait BT. The yeast nuclear pore complex: composition, architecture and transport mechanism. J. Cell Biol. 148, 635-651 (2000).
77. Robinson RA, Lange MB, Sultana R, et al. Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-b peptide of amyloid precursor protein (APP). Neuroscience 17, 207-222 (2011).
78. Ginsberg SD. Expression profile analysis of brain aging. In: Brain Aging: Models, Methods and Mechanisms. Riddle DR (Ed.). Frontiers in Neuroscience, CRC Press, FL, USA (2007).
79. Marvin-Guy L, Lopes LV, Affolter M, et al. Proteomics of the rat gut: analysis of the myenteric plexus-longitudinal muscle preparation. Proteomics 5, 2561-2569 (2005). (Pubitemid 40966483)
80. Lopes LV, Marvin-Guy LF, Fuerholz A, et al. Maternal deprivation affects the neuromuscular protein profile of the rat colon in response to an acute stressor later in life. J. Proteomics 71, 80-88 (2008). (Pubitemid 351697864)
81. Camilleri M, Heading R, Thompson WG. Consensus report: clinical perspectives, mechanisms, diagnosis and management if Irritable Bowel Syndrome. Aliment. Pharmacol. Ther. 16, 1407-1430 (2004).
82. Atkinson RJ, Hunter JO. Role of diet and bulking agents in the treatment of IBS. In: Irritable Bowel Syndrome. Camilleri M, Spiller RC, Saunders WB (Eds). Elsevier Sciences Ltd., Edinburgh, Scotland, UK, 141-150 (2002).
83. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126, 693-702 (2004). (Pubitemid 38298317)
84. Barbara G, Wang B, Stanghellini V, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132, 26-37 (2007). (Pubitemid 46108761)
85. Soderholm JD, Perdue MH. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G7-G13 (2001).
86. Nanni P, Levander F, Roda G, Caponi A, James P, Roda A. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohns disease patients. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 3127-3136 (2009).
87. Kang L, Yang ZL, Liu W, et al. Serum proteomic variation study in patients with Crohn disease. Zhonghua Wei Chang Wai Ke Za Zhi 11, 266-269 (2008).
88. Kang L, Yang ZL, Wang L, et al. Expression of CD45 in the serum of patients with Crohns disease. Nan Fang Yi Ke Da Xue Xue Bao 29, 259-263 (2009).
89. Barcelo-Batllori S, André M, Servis C, et al. Proteomic analysis of cytokine-induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. Proteomics 2, 551-560 (2002). (Pubitemid 34507345)
90. Hsieh SY, Shih TC, Yeh CY, Lin CJ, Chou YY, Lee YS. Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics 6, 5322-5331 (2006).
91. Lomnytska M, Lukiyanchuk V, Hellman U, Souchelnytskyi S. Transforming growth factor-b1-regulated proteins in human endothelial cells indentified by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 4, 995-1006 (2004). (Pubitemid 38445959)
92. Nanni P, Mezzanotte L, Roda G, et al. Differential proteomic analysis of HT29 Cl.16E and intestinal epithelial cells by LC ESI/QTOF mass spectrometry. J. Proteomics 72, 865-873 (2009).
93. Meuwis MA, FilletM, Lutteri L, et al. Proteomics for prediction and characterization of response to infliximab in Crohns disease: a pilot study. Clin. Biochem. 41, 960-967 (2008).
94. Hatsugai M, Kurokawa MS, Kouro T, et al. Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohns disease. J. Gastroenterol. 45, 488-500 (2010).
95. Kaakoush NO, Man SM, Lamb S, et al. The secretome of Campylobacter concisus. FEBS J. 277, 1606-1617 (2010).
96. Chen CS, Sullivan S, Anderson T, et al. Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip. Mol. Cell Proteomics 8, 1765-1776 (2009).
97. Shih TC, Hsieh SY, Hsieh YY, et al. Aberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis. World J. Gastroenterol. 14, 1759-1767 (2008).
98. Shkoda A, Werner T, Daniel H, Gunckel M, Rogler G, Haller D. Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease. J. Proteome Res. 6, 1114-1125 (2007). (Pubitemid 46480475)
99. Kanmura S, Uto H, Numata M, et al. Human neutrophil peptides 1-3 are useful biomarkers in patients with active ulcerative colitis. Inflamm. Bowel Dis. 15, 909-917 (2009).
100. Ding Y, Lu B, Chen D, Meng L, Shen Y, Chen S. Proteomic analysis of colonic mucosa in a rat model of irritable bowel syndrome. Proteomics 10, 2620-2630 (2010).